Antibiotic Resistance Patterns in Invasive Group B Streptococcal Isolates
Antibiotics are used for both group B streptococcal (GBS) prevention and treatment. Active population-based surveillance for invasive GBS disease was conducted in four states during 1996–2003. Of 3813 case-isolates, 91.0% (3471) were serotyped, 77.1% (2937) had susceptibility testing, and 46.6% (347...
Gespeichert in:
| Veröffentlicht in: | Infectious Diseases in Obstetrics and Gynecology 2008, Vol.2008 (2008), p.72-76 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 76 |
|---|---|
| container_issue | 2008 |
| container_start_page | 72 |
| container_title | Infectious Diseases in Obstetrics and Gynecology |
| container_volume | 2008 |
| creator | Whitney, Cynthia G. Castor, Mei L. Como-Sabetti, Kathryn Facklam, Richard R. Ferrieri, Patricia Bartkus, Joanne M. Juni, Billie A. Cieslak, Paul R. Farley, Monica M. Dumas, Nellie B. Schrag, Stephanie J. Lynfield, Ruth |
| description | Antibiotics are used for both group B streptococcal (GBS) prevention and treatment. Active population-based surveillance for invasive GBS disease was conducted in four states during 1996–2003. Of 3813 case-isolates, 91.0% (3471) were serotyped, 77.1% (2937) had susceptibility testing, and 46.6% (3471) had both. All were sensitive to penicillin, ampicillin, cefazolin, cefotaxime, and vancomycin. Clindamycin and erythromycin resistance was 12.7% and 25.6%, respectively, and associated with serotype V (P |
| doi_str_mv | 10.1155/2008/727505 |
| format | Article |
| fullrecord | <record><control><sourceid>airiti_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2637368</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><airiti_id>P20151113004_200812_201706210026_201706210026_72_76</airiti_id><sourcerecordid>P20151113004_200812_201706210026_201706210026_72_76</sourcerecordid><originalsourceid>FETCH-LOGICAL-a4845-14cf6cdbbfc57e37e959ce6f90ec7ddf13e2186d171972d35e209c4eb48474f63</originalsourceid><addsrcrecordid>eNqFkE1rFTEUhoMo9kNXrpVZW8bm5HOyEWrReqVg8WMdMpkzNuU2uSS5V_z35jql2pWrk_A-5znwEvIC6BsAKU8ZpcOpZlpS-YgcAjVDT43Rj_dvJXothDkgR6Xc0AZSJZ-SAzCMcaP0IVmdxRrGkGrw3RcsoVQXPXZXrlbMsXQhdqu4cyXssLvIabvp3nVfa8ZNTT5579bdqqS1q1iekSezWxd8fjePyfcP77-df-wvP1-szs8ueycGIXsQflZ-GsfZS41co5HGo5oNRa-naQaODAY1gQaj2cQlMmq8wLFtazErfkzeLt7NdrzFyWOs2a3tJodbl3_Z5IJ9mMRwbX-knWWKa66GJjhZBD6nUjLO97tA7b5Ru2_ULo02-tW_5_6ydxU24PUCXIc4uZ_hP7aXC4wNwdndw8LwQbKWf1pyF3Kowd6kbY6tTXvFKEgA4JSKP0ZgbYCmigGlTD38aGa14r8BaEuc6g</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Antibiotic Resistance Patterns in Invasive Group B Streptococcal Isolates</title><source>MEDLINE</source><source>Wiley Online Library Open Access</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><source>PubMed Central Open Access</source><creator>Whitney, Cynthia G. ; Castor, Mei L. ; Como-Sabetti, Kathryn ; Facklam, Richard R. ; Ferrieri, Patricia ; Bartkus, Joanne M. ; Juni, Billie A. ; Cieslak, Paul R. ; Farley, Monica M. ; Dumas, Nellie B. ; Schrag, Stephanie J. ; Lynfield, Ruth</creator><contributor>Sauve, Reginald</contributor><creatorcontrib>Whitney, Cynthia G. ; Castor, Mei L. ; Como-Sabetti, Kathryn ; Facklam, Richard R. ; Ferrieri, Patricia ; Bartkus, Joanne M. ; Juni, Billie A. ; Cieslak, Paul R. ; Farley, Monica M. ; Dumas, Nellie B. ; Schrag, Stephanie J. ; Lynfield, Ruth ; Sauve, Reginald</creatorcontrib><description>Antibiotics are used for both group B streptococcal (GBS) prevention and treatment. Active population-based surveillance for invasive GBS disease was conducted in four states during 1996–2003. Of 3813 case-isolates, 91.0% (3471) were serotyped, 77.1% (2937) had susceptibility testing, and 46.6% (3471) had both. All were sensitive to penicillin, ampicillin, cefazolin, cefotaxime, and vancomycin. Clindamycin and erythromycin resistance was 12.7% and 25.6%, respectively, and associated with serotype V (P<.001). Clindamycin resistance increased from 10.5% to 15.0% (X2 for trend 12.70; P<.001); inducible clindamycin resistance was associated with the erm genotype. Erythromycin resistance increased from 15.8% to 32.8% (X2 for trend 55.46; P<.001). While GBS remains susceptible to beta-lactams, resistance to alternative agents such as erythromycin and clindamycin is an increasing concern.</description><identifier>ISSN: 1064-7449</identifier><identifier>EISSN: 1098-0997</identifier><identifier>DOI: 10.1155/2008/727505</identifier><identifier>PMID: 19223967</identifier><language>eng</language><publisher>Cairo, Egypt: Hindawi Limiteds</publisher><subject>Anti-Bacterial Agents - pharmacology ; Colony Count, Microbial ; Dose-Response Relationship, Drug ; Drug Resistance, Bacterial ; Humans ; Microbial Sensitivity Tests ; Prevalence ; Public Health ; Serotyping ; Streptococcal Infections - drug therapy ; Streptococcus agalactiae - classification ; Streptococcus agalactiae - drug effects</subject><ispartof>Infectious Diseases in Obstetrics and Gynecology, 2008, Vol.2008 (2008), p.72-76</ispartof><rights>Copyright © 2008</rights><rights>Copyright © 2008 Mei L. Castor et al. 2008</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a4845-14cf6cdbbfc57e37e959ce6f90ec7ddf13e2186d171972d35e209c4eb48474f63</citedby><cites>FETCH-LOGICAL-a4845-14cf6cdbbfc57e37e959ce6f90ec7ddf13e2186d171972d35e209c4eb48474f63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2637368/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2637368/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,4009,27902,27903,27904,53769,53771</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19223967$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Sauve, Reginald</contributor><creatorcontrib>Whitney, Cynthia G.</creatorcontrib><creatorcontrib>Castor, Mei L.</creatorcontrib><creatorcontrib>Como-Sabetti, Kathryn</creatorcontrib><creatorcontrib>Facklam, Richard R.</creatorcontrib><creatorcontrib>Ferrieri, Patricia</creatorcontrib><creatorcontrib>Bartkus, Joanne M.</creatorcontrib><creatorcontrib>Juni, Billie A.</creatorcontrib><creatorcontrib>Cieslak, Paul R.</creatorcontrib><creatorcontrib>Farley, Monica M.</creatorcontrib><creatorcontrib>Dumas, Nellie B.</creatorcontrib><creatorcontrib>Schrag, Stephanie J.</creatorcontrib><creatorcontrib>Lynfield, Ruth</creatorcontrib><title>Antibiotic Resistance Patterns in Invasive Group B Streptococcal Isolates</title><title>Infectious Diseases in Obstetrics and Gynecology</title><addtitle>Infect Dis Obstet Gynecol</addtitle><description>Antibiotics are used for both group B streptococcal (GBS) prevention and treatment. Active population-based surveillance for invasive GBS disease was conducted in four states during 1996–2003. Of 3813 case-isolates, 91.0% (3471) were serotyped, 77.1% (2937) had susceptibility testing, and 46.6% (3471) had both. All were sensitive to penicillin, ampicillin, cefazolin, cefotaxime, and vancomycin. Clindamycin and erythromycin resistance was 12.7% and 25.6%, respectively, and associated with serotype V (P<.001). Clindamycin resistance increased from 10.5% to 15.0% (X2 for trend 12.70; P<.001); inducible clindamycin resistance was associated with the erm genotype. Erythromycin resistance increased from 15.8% to 32.8% (X2 for trend 55.46; P<.001). While GBS remains susceptible to beta-lactams, resistance to alternative agents such as erythromycin and clindamycin is an increasing concern.</description><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Colony Count, Microbial</subject><subject>Dose-Response Relationship, Drug</subject><subject>Drug Resistance, Bacterial</subject><subject>Humans</subject><subject>Microbial Sensitivity Tests</subject><subject>Prevalence</subject><subject>Public Health</subject><subject>Serotyping</subject><subject>Streptococcal Infections - drug therapy</subject><subject>Streptococcus agalactiae - classification</subject><subject>Streptococcus agalactiae - drug effects</subject><issn>1064-7449</issn><issn>1098-0997</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>RHX</sourceid><sourceid>EIF</sourceid><recordid>eNqFkE1rFTEUhoMo9kNXrpVZW8bm5HOyEWrReqVg8WMdMpkzNuU2uSS5V_z35jql2pWrk_A-5znwEvIC6BsAKU8ZpcOpZlpS-YgcAjVDT43Rj_dvJXothDkgR6Xc0AZSJZ-SAzCMcaP0IVmdxRrGkGrw3RcsoVQXPXZXrlbMsXQhdqu4cyXssLvIabvp3nVfa8ZNTT5579bdqqS1q1iekSezWxd8fjePyfcP77-df-wvP1-szs8ueycGIXsQflZ-GsfZS41co5HGo5oNRa-naQaODAY1gQaj2cQlMmq8wLFtazErfkzeLt7NdrzFyWOs2a3tJodbl3_Z5IJ9mMRwbX-knWWKa66GJjhZBD6nUjLO97tA7b5Ru2_ULo02-tW_5_6ydxU24PUCXIc4uZ_hP7aXC4wNwdndw8LwQbKWf1pyF3Kowd6kbY6tTXvFKEgA4JSKP0ZgbYCmigGlTD38aGa14r8BaEuc6g</recordid><startdate>2008</startdate><enddate>2008</enddate><creator>Whitney, Cynthia G.</creator><creator>Castor, Mei L.</creator><creator>Como-Sabetti, Kathryn</creator><creator>Facklam, Richard R.</creator><creator>Ferrieri, Patricia</creator><creator>Bartkus, Joanne M.</creator><creator>Juni, Billie A.</creator><creator>Cieslak, Paul R.</creator><creator>Farley, Monica M.</creator><creator>Dumas, Nellie B.</creator><creator>Schrag, Stephanie J.</creator><creator>Lynfield, Ruth</creator><general>Hindawi Limiteds</general><general>Hindawi Puplishing Corporation</general><general>Hindawi Publishing Corporation</general><scope>188</scope><scope>AACQA</scope><scope>ADJCN</scope><scope>AHFXO</scope><scope>RHU</scope><scope>RHW</scope><scope>RHX</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>2008</creationdate><title>Antibiotic Resistance Patterns in Invasive Group B Streptococcal Isolates</title><author>Whitney, Cynthia G. ; Castor, Mei L. ; Como-Sabetti, Kathryn ; Facklam, Richard R. ; Ferrieri, Patricia ; Bartkus, Joanne M. ; Juni, Billie A. ; Cieslak, Paul R. ; Farley, Monica M. ; Dumas, Nellie B. ; Schrag, Stephanie J. ; Lynfield, Ruth</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a4845-14cf6cdbbfc57e37e959ce6f90ec7ddf13e2186d171972d35e209c4eb48474f63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Colony Count, Microbial</topic><topic>Dose-Response Relationship, Drug</topic><topic>Drug Resistance, Bacterial</topic><topic>Humans</topic><topic>Microbial Sensitivity Tests</topic><topic>Prevalence</topic><topic>Public Health</topic><topic>Serotyping</topic><topic>Streptococcal Infections - drug therapy</topic><topic>Streptococcus agalactiae - classification</topic><topic>Streptococcus agalactiae - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Whitney, Cynthia G.</creatorcontrib><creatorcontrib>Castor, Mei L.</creatorcontrib><creatorcontrib>Como-Sabetti, Kathryn</creatorcontrib><creatorcontrib>Facklam, Richard R.</creatorcontrib><creatorcontrib>Ferrieri, Patricia</creatorcontrib><creatorcontrib>Bartkus, Joanne M.</creatorcontrib><creatorcontrib>Juni, Billie A.</creatorcontrib><creatorcontrib>Cieslak, Paul R.</creatorcontrib><creatorcontrib>Farley, Monica M.</creatorcontrib><creatorcontrib>Dumas, Nellie B.</creatorcontrib><creatorcontrib>Schrag, Stephanie J.</creatorcontrib><creatorcontrib>Lynfield, Ruth</creatorcontrib><collection>Airiti Library</collection><collection>بنك معلومات "معرفة" لدراسات العلوم العسكرية والأمنية - e-Marefa Military & Security Database</collection><collection>الدوريات العلمية والإحصائية - e-Marefa Academic and Statistical Periodicals</collection><collection>معرفة - المحتوى العربي الأكاديمي المتكامل - e-Marefa Academic Complete</collection><collection>Hindawi Publishing Complete</collection><collection>Hindawi Publishing Subscription Journals</collection><collection>Hindawi Publishing Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Infectious Diseases in Obstetrics and Gynecology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Whitney, Cynthia G.</au><au>Castor, Mei L.</au><au>Como-Sabetti, Kathryn</au><au>Facklam, Richard R.</au><au>Ferrieri, Patricia</au><au>Bartkus, Joanne M.</au><au>Juni, Billie A.</au><au>Cieslak, Paul R.</au><au>Farley, Monica M.</au><au>Dumas, Nellie B.</au><au>Schrag, Stephanie J.</au><au>Lynfield, Ruth</au><au>Sauve, Reginald</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Antibiotic Resistance Patterns in Invasive Group B Streptococcal Isolates</atitle><jtitle>Infectious Diseases in Obstetrics and Gynecology</jtitle><addtitle>Infect Dis Obstet Gynecol</addtitle><date>2008</date><risdate>2008</risdate><volume>2008</volume><issue>2008</issue><spage>72</spage><epage>76</epage><pages>72-76</pages><issn>1064-7449</issn><eissn>1098-0997</eissn><abstract>Antibiotics are used for both group B streptococcal (GBS) prevention and treatment. Active population-based surveillance for invasive GBS disease was conducted in four states during 1996–2003. Of 3813 case-isolates, 91.0% (3471) were serotyped, 77.1% (2937) had susceptibility testing, and 46.6% (3471) had both. All were sensitive to penicillin, ampicillin, cefazolin, cefotaxime, and vancomycin. Clindamycin and erythromycin resistance was 12.7% and 25.6%, respectively, and associated with serotype V (P<.001). Clindamycin resistance increased from 10.5% to 15.0% (X2 for trend 12.70; P<.001); inducible clindamycin resistance was associated with the erm genotype. Erythromycin resistance increased from 15.8% to 32.8% (X2 for trend 55.46; P<.001). While GBS remains susceptible to beta-lactams, resistance to alternative agents such as erythromycin and clindamycin is an increasing concern.</abstract><cop>Cairo, Egypt</cop><pub>Hindawi Limiteds</pub><pmid>19223967</pmid><doi>10.1155/2008/727505</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1064-7449 |
| ispartof | Infectious Diseases in Obstetrics and Gynecology, 2008, Vol.2008 (2008), p.72-76 |
| issn | 1064-7449 1098-0997 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2637368 |
| source | MEDLINE; Wiley Online Library Open Access; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Alma/SFX Local Collection; PubMed Central Open Access |
| subjects | Anti-Bacterial Agents - pharmacology Colony Count, Microbial Dose-Response Relationship, Drug Drug Resistance, Bacterial Humans Microbial Sensitivity Tests Prevalence Public Health Serotyping Streptococcal Infections - drug therapy Streptococcus agalactiae - classification Streptococcus agalactiae - drug effects |
| title | Antibiotic Resistance Patterns in Invasive Group B Streptococcal Isolates |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T06%3A06%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-airiti_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Antibiotic%20Resistance%20Patterns%20in%20Invasive%20Group%20B%20Streptococcal%20Isolates&rft.jtitle=Infectious%20Diseases%20in%20Obstetrics%20and%20Gynecology&rft.au=Whitney,%20Cynthia%20G.&rft.date=2008&rft.volume=2008&rft.issue=2008&rft.spage=72&rft.epage=76&rft.pages=72-76&rft.issn=1064-7449&rft.eissn=1098-0997&rft_id=info:doi/10.1155/2008/727505&rft_dat=%3Cairiti_pubme%3EP20151113004_200812_201706210026_201706210026_72_76%3C/airiti_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/19223967&rft_airiti_id=P20151113004_200812_201706210026_201706210026_72_76&rfr_iscdi=true |